Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

RetractionCardiology Free access | 10.1172/JCI32865R1

Curcumin prevents and reverses murine cardiac hypertrophy

Hong-Liang Li, Chen Liu, Geoffrey de Couto, Maral Ouzounian, Mei Sun, Ai-Bing Wang, Yue Huang, Cheng-Wei He, Yu Shi, Xin Chen, Mai P. Nghiem, Youan Liu, Manyin Chen, Fayez Dawood, Masahiro Fukuoka, Yuichiro Maekawa, Liyong Zhang, Andrew Leask, Asish K. Ghosh, Lorrie A. Kirshenbaum, and Peter P. Liu

Find articles by Li, H. in: JCI | PubMed | Google Scholar

Find articles by Liu, C. in: JCI | PubMed | Google Scholar

Find articles by de Couto, G. in: JCI | PubMed | Google Scholar

Find articles by Ouzounian, M. in: JCI | PubMed | Google Scholar

Find articles by Sun, M. in: JCI | PubMed | Google Scholar

Find articles by Wang, A. in: JCI | PubMed | Google Scholar

Find articles by Huang, Y. in: JCI | PubMed | Google Scholar

Find articles by He, C. in: JCI | PubMed | Google Scholar

Find articles by Shi, Y. in: JCI | PubMed | Google Scholar

Find articles by Chen, X. in: JCI | PubMed | Google Scholar

Find articles by Nghiem, M. in: JCI | PubMed | Google Scholar

Find articles by Liu, Y. in: JCI | PubMed | Google Scholar

Find articles by Chen, M. in: JCI | PubMed | Google Scholar

Find articles by Dawood, F. in: JCI | PubMed | Google Scholar

Find articles by Fukuoka, M. in: JCI | PubMed | Google Scholar

Find articles by Maekawa, Y. in: JCI | PubMed | Google Scholar

Find articles by Zhang, L. in: JCI | PubMed | Google Scholar

Find articles by Leask, A. in: JCI | PubMed | Google Scholar

Find articles by Ghosh, A. in: JCI | PubMed | Google Scholar

Find articles by Kirshenbaum, L. in: JCI | PubMed | Google Scholar

Find articles by Liu, P. in: JCI | PubMed | Google Scholar

Published July 1, 2009 - More info

Published in Volume 119, Issue 7 on July 1, 2009
J Clin Invest. 2009;119(7):2113–2113. https://doi.org/10.1172/JCI32865R1.
© 2009 The American Society for Clinical Investigation
Published July 1, 2009 - Version history
View PDF

Related article:

Curcumin prevents and reverses murine cardiac hypertrophy
Hong-Liang Li, … , Lorrie A. Kirshenbaum, Peter P. Liu
Hong-Liang Li, … , Lorrie A. Kirshenbaum, Peter P. Liu
Research Article

Curcumin prevents and reverses murine cardiac hypertrophy

  • Text
  • PDF
Abstract

Chromatin remodeling, particularly histone acetylation, plays a critical role in the progression of pathological cardiac hypertrophy and heart failure. We hypothesized that curcumin, a natural polyphenolic compound abundant in the spice turmeric and a known suppressor of histone acetylation, would suppress cardiac hypertrophy through the disruption of p300 histone acetyltransferase–dependent (p300-HAT–dependent) transcriptional activation. We tested this hypothesis using primary cultured rat cardiac myocytes and fibroblasts as well as two well-established mouse models of cardiac hypertrophy. Curcumin blocked phenylephrin-induced (PE-induced) cardiac hypertrophy in vitro in a dose-dependent manner. Furthermore, curcumin both prevented and reversed mouse cardiac hypertrophy induced by aortic banding (AB) and PE infusion, as assessed by heart weight/BW and lung weight/BW ratios, echocardiographic parameters, and gene expression of hypertrophic markers. Further investigation demonstrated that curcumin abrogated histone acetylation, GATA4 acetylation, and DNA-binding activity through blocking p300-HAT activity. Curcumin also blocked AB-induced inflammation and fibrosis through disrupting p300-HAT–dependent signaling pathways. Our results indicate that curcumin has the potential to protect against cardiac hypertrophy, inflammation, and fibrosis through suppression of p300-HAT activity and downstream GATA4, NF-κB, and TGF-β–Smad signaling pathways.

Authors

Hong-Liang Li, Chen Liu, Geoffrey de Couto, Maral Ouzounian, Mei Sun, Ai-Bing Wang, Yue Huang, Cheng-Wei He, Yu Shi, Xin Chen, Mai P. Nghiem, Youan Liu, Manyin Chen, Fayez Dawood, Masahiro Fukuoka, Yuichiro Maekawa, Liyong Zhang, Andrew Leask, Asish K. Ghosh, Lorrie A. Kirshenbaum, Peter P. Liu

×

Original citation: J. Clin. Invest.118:879–893 (2008). doi:10.1172/JCI32865.

Citation for this corrigendum: J. Clin. Invest.119:2113 (2009). doi:10.1172/JCI32865R1.

During the preparation of the manuscript, different fields of the same sample for WGA immunofluorescence staining were mistakenly used to represent 2 distinct treatment groups on 2 occasions, in Figures 2 and 7, and some of the raw data for the earlier experiments were lost due to poor record keeping. All authors have agreed to retract the article. The authors sincerely apologize for any inconvenience this action has caused.

Version history
  • Version 1 (July 1, 2009): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts